Literature DB >> 6169388

Localisation of malignant germ-cell tumours by external scanning after injection of radiolabelled anti-alpha-fetoprotein.

A K Halsall, D S Fairweather, A R Bradwell, J C Blackburn, P W Dykes, A Howell, A Reeder, K R Hine.   

Abstract

Sheep IgG antibody to alpha-fetoprotein was labelled with 131I and used to identify human germ-cell tumours by emission scanning. Eleven patients were studied after resection of their primary tumours. Ten had malignant teratoma and one an endodermal sinus tumour. All eight patients with raised serum alpha-fetoprotein concentrations had metastases apparent in the antibody scans. Of the remaining three patients with normal serum alpha-fetoprotein concentrations, two had positive scans. Three of the patients with positive results were scanned twice; the second scans were negative after treatment, when the alpha-fetoprotein concentrations had returned to normal. These result suggest that antibody scans are useful in the clinical management of patients with germ-cell tumours.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6169388      PMCID: PMC1507167          DOI: 10.1136/bmj.283.6297.942

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  10 in total

1.  The role of biologic tumor markers in testicular cancer.

Authors:  N Javadpour
Journal:  Cancer       Date:  1980-04-15       Impact factor: 6.860

2.  Radiolabeling of antibodies.

Authors:  W C Eckelman; C H Paik; R C Reba
Journal:  Cancer Res       Date:  1980-08       Impact factor: 12.701

3.  Normal lymphatic drainage of the testis studied by funicular lymphography.

Authors:  L Wahlqvist; L Hultén; M Rosencrantz
Journal:  Acta Chir Scand       Date:  1966-10

4.  Combination radical surgery and multiple sequential chemotherapy for the treatment of advanced carcinoma of the testis (stage III).

Authors:  C Merrin; H Takita; R Weber; Z Wajsman; G Baumgartner; G P Murphy
Journal:  Cancer       Date:  1976-01       Impact factor: 6.860

5.  Preliminary therapeutic and localization studies with human chorionic gonadotrophin.

Authors:  K D Bagshawe; F Searle; J Lewis; P Brown; P Keep
Journal:  Cancer Res       Date:  1980-08       Impact factor: 12.701

6.  Use of radiolabeled antibodies to carcinoembryonic antigen for the detection and localization of diverse cancers by external photoscanning.

Authors:  D M Goldenberg; F DeLand; E Kim; S Bennett; F J Primus; J R van Nagell; N Estes; P DeSimone; P Rayburn
Journal:  N Engl J Med       Date:  1978-06-22       Impact factor: 91.245

7.  Clinical studies on the radioimmunodetection of tumors containing alpha-fetoprotein.

Authors:  D M Goldenberg; E E Kim; F Deland; E Spremulli; M O Nelson; J P Gockerman; F J Primus; R L Corgan; E Alpert
Journal:  Cancer       Date:  1980-05-15       Impact factor: 6.860

8.  Radioimmunodetection of cancer with radiolabeled antibodies to alpha-fetoprotein.

Authors:  E E Kim; F H DeLand; M O Nelson; S Bennett; G Simmons; E Alpert; D M Goldenberg
Journal:  Cancer Res       Date:  1980-08       Impact factor: 12.701

9.  Localisation of tumour deposits by external scanning after injection of radiolabelled anti-carcinoembryonic antigen.

Authors:  P W Dykes; K R Hine; A R Bradwell; J C Blackburn; T A Reeder; Z Drolc; S N Booth
Journal:  Br Med J       Date:  1980-01-26

10.  Tumor localization of radiolabeled antibodies against carcinoembryonic antigen in patients with carcinoma: a critical evaluation.

Authors:  J P Mach; S Carrel; M Forni; J Ritschard; A Donath; P Alberto
Journal:  N Engl J Med       Date:  1980-07-03       Impact factor: 91.245

  10 in total
  6 in total

Review 1.  Immunoscintigraphy for cancer detection: "a thousand ills require a thousand cures".

Authors:  S H de Bie; T C Ferreira; E K Pauwels; F J Cleton
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

2.  Radioimmunoscintigraphy of ovarian cancer with 131-iodine labeled OC-125 antibody fragments.

Authors:  G Barzen; A C Mayr; M Langer; R Becker; M Cordes; C Zwicker; K Koppenhagen; R Felix
Journal:  Eur J Nucl Med       Date:  1989

3.  Immunoscintigraphy with 131I-labelled H17E2 monoclonal antibody compared with conventional lymphangiography and computed tomography in the detection of metastases in patients with testicular germ cell tumours.

Authors:  D Pectasides; P Vonorta; A Tsialta-Salihou; K Pateniotis; V Barbounis; H Kayianni; P Arapantoni; J Taylor-Papadimitriou; A Epenetos; P Koutsiouba
Journal:  Br J Cancer Suppl       Date:  1990-07

4.  Radioimmunolocalization of human brain tumours: biodistribution of radiolabelled monoclonal antibody UJ13A.

Authors:  R B Richardson; A G Davies; S P Bourne; G E Staddon; D H Jones; J T Kemshead; H B Coakham
Journal:  Eur J Nucl Med       Date:  1986

5.  Improved tumour localisation using indium-111 labelled antibodies.

Authors:  D S Fairweather; A R Bradwell; P W Dykes; A T Vaughan; S F Watson-James; S Chandler
Journal:  Br Med J (Clin Res Ed)       Date:  1983-07-16

Review 6.  Scanning for tumours with radiolabelled antibodies: a review.

Authors:  P W Dykes; A R Bradwell; D S Fairweather
Journal:  J R Soc Med       Date:  1983-11       Impact factor: 18.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.